Brief: Qualigen Therapeutics, Inc. Reports Q4 Financial Results
May 2 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. REPORTS FOURTH QUARTER AND
YEAR-END
2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* QUALIGEN THERAPEUTICS INC FY LOSS PER SHARE $4.85
Source text for Eikon: ID:nGNX8SFcN4
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on FF EAI Robotics Ecosystem
See all newsBrief: Faraday Future Intelligent Electric Says FFR To Operate Robotics Business
Brief: Faraday Future Signs Deal to Transfer Robotics Business to FFR at $200 Mln Valuation
Faraday Future climbs after robotics unit deal, strategic upgrade into robotaxi operator
Brief: Aixcrypto Provides Context On Schedule 14C Filing
NASDAQ RESUMED AT 12:42 PM